Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ZNF300 promotes chemoresistance and aggressive behaviour in non‐small‐cell lung cancer

19 Oct 2020

Abstract excerpt

OBJECTIVES: Chemoresistance induced by cisplatin has become the major impediment to lung cancer chemotherapy. This study explored the potential chemoresistant genes and underlying mechanisms of chemoresistance in NSCLC. MATERIALS AND METHODS: Gene expression profile was integrated with DNA methylation profile to screen the candidate chemoresistant genes. Bioinformatic analysis and immunohistochemistry were used...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Lung Cancer Treatments and Mutations
Share to Microtubule and mitosis dynamics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33078469
DOI: 10.1111/cpr.12924

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ZNF300 promotes chemoresistance and aggressive behaviour in non‐small‐cell lung cancerPMID 33078469Read ↗

MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray dataSemantic proximity Read ↗

Regulation of cisplatin resistance in lung cancer by epigenetic mechanismsSemantic proximity Read ↗

Overcoming of Radioresistance in Non-small Cell Lung Cancer by microRNA-320a Through HIF1α-Suppression Mediated Methylation of PTENSemantic proximity Read ↗

Abnormal genome-wide DNA methylation induced by cisplatin may contribute to the chemo-resistance of human small cell lung cancerSemantic proximity Read ↗

Targeting the miR-6734-3p/ZEB2 axis hampers development of non-small cell lung cancer (NSCLC) and increases susceptibility of cancer cells to cisplatin treatment.Semantic proximity Read ↗

ZNF488 Enhances the Invasion and Metastasis through Activating the MAPK/ERK Signaling Pathway in Non-Small Cell Lung CancerSemantic proximity Read ↗

KANK1 regulates paclitaxel resistance in lung adenocarcinoma A549 cellsSemantic proximity Read ↗

MicroRNA‑103a‑3p potentiates chemoresistance to cisplatin in non‑small cell lung carcinoma by targeting neurofibromatosis 1Semantic proximity Read ↗

NFIB controls chemosensitivity in small cell lung cancer by suppressing Notch signaling activitySemantic proximity Read ↗

<i>SIRT2, TFEB, CNIH3, ADRM1</i> , AND <i>TM9SF4</i> AS POTENTIAL BIOMARKERS OF RESISTANCE TO CRIZOTINIB AND POOR PROGNOSIS IN LUNG ADENOCARCINOMA: IMPLICATIONS FOR TARGETED THERAPY AND IMMUNOTHERAPYSemantic proximity Read ↗

ZNF652 exerts a tumor suppressor role in lung cancer by transcriptionally downregulating cyclin D3Semantic proximity Read ↗

ZNF 703 Overexpression may act as an oncogene in non‐small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.